| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/27/2009 | US20090214549 Antigenic Epitopes Of Inteleukin-21, Related Antibodies And Their Use In Medical Field |
| 08/27/2009 | US20090214548 TGR3-Like Protein Receptor |
| 08/27/2009 | US20090214547 Binding member towards pneumolysin |
| 08/27/2009 | US20090214546 Novel therapeutic targets in cancer |
| 08/27/2009 | US20090214545 multiple myeloma, acute myelogenous leukemia or chromic myelogenous leukemia; time-release and sustained-release drugs |
| 08/27/2009 | US20090214544 Method of treating cd30 positive lymphomas |
| 08/27/2009 | US20090214543 Methods for treating cancer using an immuno-toxin comprising an exotoxin a moiety having a furin cleavage site replaced with a cancer associated protease site cleaved by mmp-2 or mmp-9 |
| 08/27/2009 | US20090214542 Novel therapeutic targets in cancer |
| 08/27/2009 | US20090214541 Combination Therapy Using Anti-EGFR and Anti-HER2 Antibodies |
| 08/27/2009 | US20090214540 Protein involved in cancer |
| 08/27/2009 | US20090214539 B-cell reduction using cd37-specific and cd20-specific binding molecules |
| 08/27/2009 | US20090214538 Use of complement inhibitors to treat ocular diseases |
| 08/27/2009 | US20090214537 Serum Resistance Factors of Gram Positive Bacteria |
| 08/27/2009 | US20090214536 CACNA1E in Cancer Diagnosis, Detection and Treatment |
| 08/27/2009 | US20090214535 Pharmaceutical Compositions Containing sc(Fv)2 |
| 08/27/2009 | US20090214534 Bispecific Domain Antibodies Targeting Serum Albumin And GLP-1 Or PYY |
| 08/27/2009 | US20090214533 Methods for converting or inducing protective immunity |
| 08/27/2009 | US20090214532 ANKTM1, A Cold-Activated TRP-Like Channel Expressed in Nociceptive Neurons |
| 08/27/2009 | US20090214531 Methods and Compositions for Treating and Preventing Bacterial Infections |
| 08/27/2009 | US20090214530 MODIFIED CpG OLIGODEOXYNUCLEOTIDE WITH IMPROVED IMMUNOREGULATORY FUNCTION |
| 08/27/2009 | US20090214529 Kinesin inhibitors |
| 08/27/2009 | US20090214528 Host cell lines for production of antibody constant region with enhanced effector function |
| 08/27/2009 | US20090214527 Combination Of Anti-Madcam Antibody And Antifibrotic Caspase Inhibitor To Treat Liver Fibrosis |
| 08/27/2009 | US20090214526 For use as antibody biodrug with improved therapeutic, production properties |
| 08/27/2009 | US20090214525 Novel anti-igf-ir antibodies and uses thereof |
| 08/27/2009 | US20090214524 Methods and compositions for regulating cell cycle checkpoints |
| 08/27/2009 | US20090214523 Novel anti-IL13 antibodies and uses thereof |
| 08/27/2009 | US20090214522 Process for concentration of antibodies and therapeutic products thereof |
| 08/27/2009 | US20090214521 Bone morphogenetic protein-2 in the treatment and diagnosis of cancer |
| 08/27/2009 | US20090214520 Soluble CLCA-1 and antagonists to CLCA-1 |
| 08/27/2009 | US20090214519 Compositions and Methods for Treating Inflammation |
| 08/27/2009 | US20090214518 Methods and compositions for treating solid tumors and enhancing tumor vaccines |
| 08/27/2009 | US20090214517 Compositions and methods of use for modulators of nectin 4, semaphorin 4b, igsf9, and kiaa0152 in treating disease |
| 08/27/2009 | US20090214516 Inhibitors of Reglll Proteins as Asthma Therapeutics |
| 08/27/2009 | US20090214515 Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins |
| 08/27/2009 | US20090214514 Gus3 neuropeptides for regulating hypothalamic function |
| 08/27/2009 | US20090214492 Isolated stromal cells for use in the treatment of diseases of the central nervous system |
| 08/27/2009 | US20090214470 Eye-drop vaccine containing copolymer 1 for therapeutic immunization |
| 08/27/2009 | US20090214466 Methods of Alleviating Disorders and Their Associated Pain |
| 08/27/2009 | US20090214465 Quinoxaline Derivatives as Antitumor Agents |
| 08/27/2009 | US20090214438 Methods and compositions for the preparation and use of toxin conjugates |
| 08/27/2009 | US20090214431 Identification of ergothioneine transporter and therapeutic uses thereof |
| 08/27/2009 | US20090214428 Human Monoclonal Antibodies Against Hendra and Nipah Viruses |
| 08/27/2009 | US20090214424 Human glycoprotein hormone superagonists and uses thereof |
| 08/27/2009 | US20090214422 DNA encoding a novel RG1 polypeptide |
| 08/27/2009 | US20090214421 ANTIBODY DIRECTED AGAINST PAP2a AND USE THEREOF FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES |
| 08/27/2009 | US20090214420 Method of Diagnosis and Treatment and Agents Useful for Same |
| 08/27/2009 | DE102008010727A1 Bacterial O-antigen based active immunization, useful e.g. to promote formation of O-antigen-sensitive antibodies, comprises parenteral administration of O-antigen saccharide from e.g. Escherichia coli pathotypes in a suspension |
| 08/27/2009 | CA2844188A1 Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof |
| 08/27/2009 | CA2752851A1 Treatment and prevention of dry age-related macular degeneration by activating cd36 |
| 08/27/2009 | CA2716340A1 Immunogenic influenza composition |
| 08/27/2009 | CA2716321A1 Methods for treating cancer using combination therapy |
| 08/27/2009 | CA2716212A1 Meningococcal fhbp polypeptides |
| 08/27/2009 | CA2716210A1 Escherichia coli immunogens with improved solubility |
| 08/27/2009 | CA2716187A1 Bioconjugates made from recombinant n-glycosylated proteins from procaryotic cells |
| 08/27/2009 | CA2716110A1 Ophthalmic nsaids as adjuvants |
| 08/27/2009 | CA2716007A1 Mimotope |
| 08/27/2009 | CA2715632A1 Synthetic scfv analogue to the 6313/g2 (anti angiotensin ii type 1 receptor) monoclonal antibody variable regions |
| 08/27/2009 | CA2715324A1 Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof |
| 08/27/2009 | CA2715237A1 Virus-like particles as vaccines for paramyxovirus |
| 08/27/2009 | CA2714939A1 Use of therapeutic peptides for the treatment and prevention of cancer |
| 08/27/2009 | CA2714296A1 Humanized anti-c5ar antibodies |
| 08/27/2009 | CA2712474A1 Procedure for the generation of a high producer cell line for the expression of a recombinant anti-cd34 antibody |
| 08/26/2009 | EP2093298A2 Compositions for diagnosis and therapy of diseases associated with aberrant expression of Futrins (R-Spondins) |
| 08/26/2009 | EP2093294A1 Nucleotide and protein sequences of Nogo genes and methods based thereon |
| 08/26/2009 | EP2093237A1 Cancer therapeutic agent comprising anti-hb-egf antibody as active ingredient |
| 08/26/2009 | EP2092939A2 Therapeutical use of antibody inducing the production of cytokines |
| 08/26/2009 | EP2092067A1 Microorganisms as carriers of nucleotide sequences coding for antigens and protein toxins, process of manufacturing and uses thereof |
| 08/26/2009 | EP2092058A1 Cancerous disease modifying antibodies |
| 08/26/2009 | EP2091975A2 Anti-egfr family antibodies, bispecific anti-egfr family antibodies and methods of use thereof |
| 08/26/2009 | EP2091972A1 Multi-modal cancer therapy using viral hitch-hiking |
| 08/26/2009 | EP2091971A2 Therapeutic targeting of escort proteins |
| 08/26/2009 | EP2091970A2 Inhibition of platelet aggregation |
| 08/26/2009 | EP2091969A2 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods |
| 08/26/2009 | EP2091965A1 Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides |
| 08/26/2009 | EP2091963A2 New antigens for paratuberculosis diagnosis and vaccination |
| 08/26/2009 | EP2091611A2 New drug for treating gastric cancer |
| 08/26/2009 | EP2091564A2 Method of inhibiting coagulation with human anti-factor va antibodies and use thereof |
| 08/26/2009 | EP2091563A2 Neutralizing monoclonal antibodies against the nogo-66 receptor (ngr) and uses thereof |
| 08/26/2009 | EP2091562A1 Il- 18 vaccine for the treatment of various inflammatory conditions. |
| 08/26/2009 | EP2091561A2 Method for replicating influenza virus in culture |
| 08/26/2009 | EP2091560A1 Feline vaccines against avian influenza |
| 08/26/2009 | EP2091559A1 Vaccination of horses against lawsonia intracellularis |
| 08/26/2009 | EP2091558A2 Methods of enhancing immune response using electroporation-assisted vaccination and boosting |
| 08/26/2009 | EP1624891B1 Clotting factor-fc chimeric proteins to treat hemophilia |
| 08/26/2009 | EP1601694B1 Uses of il-23 antagonists; related reagents |
| 08/26/2009 | EP1561759B9 Cell death-inducing agent |
| 08/26/2009 | EP1530584B1 Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses |
| 08/26/2009 | EP1450855B1 Suppression of allergic reactions by transdermal administration of allergens in conjunction with or conjugated to toxin subunits or fragments thereof |
| 08/26/2009 | EP1423428B1 Antibodies that block fgfr3 activation, methods of screening for and uses thereof |
| 08/26/2009 | EP1368057B1 Method to enhance the immunogenicity of an antigen |
| 08/26/2009 | EP1299524B1 Human myeloma cell line |
| 08/26/2009 | EP1297005B1 Immunisation against chlamydia pneumoniae |
| 08/26/2009 | EP1296714B1 Combination of CpG and antibodies directed against CD19,CD20, CD22 or CD40 for the treatment or prevention of cancer. |
| 08/26/2009 | EP1237915B1 Polynucleotid encoding the rg1 polypeptide |
| 08/26/2009 | EP1147212B1 T helper cell epitopes |
| 08/26/2009 | EP1007700B1 Monoclonal antibody against a prion protein and its use for the detection of prions |
| 08/26/2009 | CN101517075A Cell death inducer |
| 08/26/2009 | CN101516914A Antibodies against CCR5 and uses thereof |
| 08/26/2009 | CN101516913A Antibody having enhanced ADCC activity and method for production thereof |